|
|
|
||||
|
|
|||||
|
Computerized results of Menopause Type® Questionnaire: |
|||||
|
Menopause Type® Eight |
|||||
|
Menopause Type® Eight has symptoms that reveal decreased
progesterone function, decreased testosterone function with adequate
estradiol function. Health risks associated with Menopause Type® Eight may include
decreased muscle mass, osteoporosis, some forms of cancer and heart disease.
Because progesterone and testosterone function is suboptimal, they are often
unable to properly oppose the actions of estrogen. This may appear to have
“estrogen dominance”, even though estrogen levels are not excessive. Once
progesterone and testosterone are supported to normal function, any minor
“estrogen excess” symptoms and risks are usually rapidly corrected. |
See Pages
133-139 |
||||
|
PROTOCOL: The following protocol provides women with Menopause
Type® 8 information on which nutritional and herbal formulations
can support the normal function of hormone responsive tissues. Please review the Advanced Integrative Management of
Menopause document for more detailed information. |
|||||
|
Foundational Interventions: |
|||||
|
Foundational interventions include lifestyle and dietary choices that support optimal hormone function. In addition, a high grade multiple vitamin mineral formulation rich in antioxidants and essential fatty acids rich in docosahexaenoic acid are required for optimal hormone function. |
|||||
|
Ultra Preventive® X V-Cap - A high grade multiple
vitamin and mineral supplement with significant antioxidant support. Vitamins
and minerals are
cofactors required for every biochemical process in the human body, including
the production and proper detoxification of hormones. Oxygen stress
contributes to some of the pathophysiolgical effects of suboptimal menopause.
These effects may be prevented and/or treated by improving the antioxidant
defense of perimenopause, menopause, and postmenopausal women. |
|||||
|
Opti DHA - An essential fatty acid rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), with a high DHA:EPA ratio. The essential fatty acid DHA help maintain ideal cell membrane fluidity allowing optimal transport of molecules across the membrane, which is critical for hormone function, while EPA helps the body control inflammation. |
|||||
|
Primary Endocrine Formulations : |
|||||
|
Primary
Endocrine Nutraceutical formulations should be used to support the function
of hormone producing glands and hormone responsive tissues. The primary formulations that are
appropriate to manage hormonal imbalances observed in Menopause Type® Eight include: |
|||||
|
Progesto-Mend™ is a unique blend of phytoprogesterones, adaptogens and other herbs
to naturally support hormonal balance
by supporting the ideal function of progesterone producing tissues and of
progesterone responsive tissues as needed in Menopause Type®
Eight. More
Information on Progesto-Mend™ |
|||||
|
Testo-Gain™, a unique
blend of phytoandrogens, adaptogens and other herbs to naturally support
hormonal balance by supporting the
ideal function of testosterone producing tissues and of testosterone
responsive tissues as needed in Menopause Type® Eight. More
Information on Testo-Gain™ |
|||||
|
Please Find a Healthcare Professional in your area to customize these protocols. |
|||||
|
Secondary Endocrine Formulations: |
|||||
|
Since decreased thyroid
function can adversely affect the function of other hormones, a nutraceutical formulation to support the function
of the thyroid gland and the liver (which converts T4 to T3)
and also supports the function and response of tissues that respond to
thyroid hormones should be used if there are signs and symptoms of decreased thyroid function. There is always some risk for decreased blood glucose function in women of menopause age, so
evaluation of glucose function and insulin resistance should be done as part
routine health assessment. Excessive body weight also increases the risk for decreased blood glucose function. A nutraceutical formulation to support healthy blood
glucose function should be used if there are signs and symptoms of decreased blood sugar function. |
|||||
|
Thyro-Mend™ is a synergistic
combination of iodine containing seaweeds, and herbs which contain
phytothyroidogenic, phyto-thyroid-receptor agonists, and other herbs designed
to promote optimal function of thyroid hormones by maintaining the health of
thyroid hormone producing tissues and by supporting the healthy function of
tissues that respond to thyroid hormones. More information on Thyro-Mend™. |
|||||
|
Glucobrium
is a synergistic formulation of phytotherapeutic extracts which mimic and
potentiate the actions of insulin and support healthy blood glucose function.
More information on Glucobrium. |
|||||
|
When to Consider
Hormone Precursors & Bioidentical Hormone Replacement Therapy |
|||||
|
Hormone precursors such as Pregnenolone 25 Mg Tab, DHEA 5 MG and 7-KETO may be used to support hormone production pathways that create
progesterone and testosterone. They have mild hormone actions in and of
themselves, and do not have the same risks that are associated with Hormone
Replacement Therapies (HRT). Bioidentical
Hormone Replacement Therapy (BHRT), while considered more appropriate than
synthetic hormone therapies, does not support the hormone production
pathways, but instead provides “replacement”, which may further diminish
endogenous hormone production. Evaluation
of hormone levels, use of hormone precursors as needed, and as a final course of action, the prescription
of bioidentical hormone therapies should be considered only when
restoration of normal function is not possible. |
|||||
|
Also Review: |
|||||
|
Make the Right Choice |
|||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown
such commitment as to take an extensive course of study on menopause type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a Healthcare Professional . |
|||||
|
How Your
Menopause Type® Was Calculated
(www.YourMenopauseType.com/Questionnaire.html#Calculate) |
|||||
|
|
|||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
|||||
|
Review Disclaimer & Legal
(www.YourMenopauseType.com/Disclaimer) |
|||||
YourMenopauseType.com,
Inc.
|
|||||
|
Last update
03/18/07 |
|||||
|
|
|||||